Cargando…

Creatine Fails to Augment the Benefits from Resistance Training in Patients with HIV Infection: A Randomized, Double-Blind, Placebo-Controlled Study

BACKGROUND: Progressive resistance exercise training (PRT) improves physical functioning in patients with HIV infection. Creatine supplementation can augment the benefits derived from training in athletes and improve muscle function in patients with muscle wasting. The objective of this study was to...

Descripción completa

Detalles Bibliográficos
Autores principales: Sakkas, Giorgos K., Mulligan, Kathleen, DaSilva, Makani, Doyle, Julie W., Khatami, Hootan, Schleich, Thomas, Kent-Braun, Jane A., Schambelan, Morris
Formato: Texto
Lenguaje:English
Publicado: Public Library of Science 2009
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2646129/
https://www.ncbi.nlm.nih.gov/pubmed/19242554
http://dx.doi.org/10.1371/journal.pone.0004605
_version_ 1782164822372122624
author Sakkas, Giorgos K.
Mulligan, Kathleen
DaSilva, Makani
Doyle, Julie W.
Khatami, Hootan
Schleich, Thomas
Kent-Braun, Jane A.
Schambelan, Morris
author_facet Sakkas, Giorgos K.
Mulligan, Kathleen
DaSilva, Makani
Doyle, Julie W.
Khatami, Hootan
Schleich, Thomas
Kent-Braun, Jane A.
Schambelan, Morris
author_sort Sakkas, Giorgos K.
collection PubMed
description BACKGROUND: Progressive resistance exercise training (PRT) improves physical functioning in patients with HIV infection. Creatine supplementation can augment the benefits derived from training in athletes and improve muscle function in patients with muscle wasting. The objective of this study was to determine whether creatine supplementation augments the effects of PRT on muscle strength, energetics, and body composition in HIV-infected patients. METHODOLOGY/PRINCIPAL FINDINGS: This is a randomized, double blind, placebo-controlled, clinical research center-based, outpatient study in San Francisco. 40 HIV–positive men (20 creatine, 20 placebo) enrolled in a 14-week study. Subjects were randomly assigned to receive creatine monohydrate or placebo for 14 weeks. Treatment began with a loading dose of 20 g/day or an equivalent number of placebo capsules for 5 days, followed by maintenance dosing of 4.8 g/day or placebo. Beginning at week 2 and continuing to week 14, all subjects underwent thrice-weekly supervised resistance exercise while continuing on the assigned study medication (with repeated 6-week cycles of loading and maintenance). The main outcome measurements included muscle strength (one repetition maximum), energetics ((31)P magnetic resonance spectroscopy), composition and size (magnetic resonance imaging), as well as total body composition (dual-energy X-ray absorptiometry). Thirty-three subjects completed the study (17 creatine, 16 placebo). Strength increased in all 8 muscle groups studied following PRT, but this increase was not augmented by creatine supplementation (average increase 44 vs. 42%, difference 2%, 95% CI −9.5% to 13.9%) in creatine and placebo, respectively). There were no differences between groups in changes in muscle energetics. Thigh muscle cross-sectional area increased following resistance exercise, with no additive effect of creatine. Lean body mass (LBM) increased to a significantly greater extent with creatine. CONCLUSIONS / SIGNIFICANCE: Resistance exercise improved muscle size, strength and function in HIV-infected men. While creatine supplementation produced a greater increase in LBM, it did not augment the robust increase in strength derived from PRT. TRIAL REGISTRATION: ClinicalTrials.gov NCT00484627
format Text
id pubmed-2646129
institution National Center for Biotechnology Information
language English
publishDate 2009
publisher Public Library of Science
record_format MEDLINE/PubMed
spelling pubmed-26461292009-02-26 Creatine Fails to Augment the Benefits from Resistance Training in Patients with HIV Infection: A Randomized, Double-Blind, Placebo-Controlled Study Sakkas, Giorgos K. Mulligan, Kathleen DaSilva, Makani Doyle, Julie W. Khatami, Hootan Schleich, Thomas Kent-Braun, Jane A. Schambelan, Morris PLoS One Research Article BACKGROUND: Progressive resistance exercise training (PRT) improves physical functioning in patients with HIV infection. Creatine supplementation can augment the benefits derived from training in athletes and improve muscle function in patients with muscle wasting. The objective of this study was to determine whether creatine supplementation augments the effects of PRT on muscle strength, energetics, and body composition in HIV-infected patients. METHODOLOGY/PRINCIPAL FINDINGS: This is a randomized, double blind, placebo-controlled, clinical research center-based, outpatient study in San Francisco. 40 HIV–positive men (20 creatine, 20 placebo) enrolled in a 14-week study. Subjects were randomly assigned to receive creatine monohydrate or placebo for 14 weeks. Treatment began with a loading dose of 20 g/day or an equivalent number of placebo capsules for 5 days, followed by maintenance dosing of 4.8 g/day or placebo. Beginning at week 2 and continuing to week 14, all subjects underwent thrice-weekly supervised resistance exercise while continuing on the assigned study medication (with repeated 6-week cycles of loading and maintenance). The main outcome measurements included muscle strength (one repetition maximum), energetics ((31)P magnetic resonance spectroscopy), composition and size (magnetic resonance imaging), as well as total body composition (dual-energy X-ray absorptiometry). Thirty-three subjects completed the study (17 creatine, 16 placebo). Strength increased in all 8 muscle groups studied following PRT, but this increase was not augmented by creatine supplementation (average increase 44 vs. 42%, difference 2%, 95% CI −9.5% to 13.9%) in creatine and placebo, respectively). There were no differences between groups in changes in muscle energetics. Thigh muscle cross-sectional area increased following resistance exercise, with no additive effect of creatine. Lean body mass (LBM) increased to a significantly greater extent with creatine. CONCLUSIONS / SIGNIFICANCE: Resistance exercise improved muscle size, strength and function in HIV-infected men. While creatine supplementation produced a greater increase in LBM, it did not augment the robust increase in strength derived from PRT. TRIAL REGISTRATION: ClinicalTrials.gov NCT00484627 Public Library of Science 2009-02-26 /pmc/articles/PMC2646129/ /pubmed/19242554 http://dx.doi.org/10.1371/journal.pone.0004605 Text en Sakkas et al. http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are properly credited.
spellingShingle Research Article
Sakkas, Giorgos K.
Mulligan, Kathleen
DaSilva, Makani
Doyle, Julie W.
Khatami, Hootan
Schleich, Thomas
Kent-Braun, Jane A.
Schambelan, Morris
Creatine Fails to Augment the Benefits from Resistance Training in Patients with HIV Infection: A Randomized, Double-Blind, Placebo-Controlled Study
title Creatine Fails to Augment the Benefits from Resistance Training in Patients with HIV Infection: A Randomized, Double-Blind, Placebo-Controlled Study
title_full Creatine Fails to Augment the Benefits from Resistance Training in Patients with HIV Infection: A Randomized, Double-Blind, Placebo-Controlled Study
title_fullStr Creatine Fails to Augment the Benefits from Resistance Training in Patients with HIV Infection: A Randomized, Double-Blind, Placebo-Controlled Study
title_full_unstemmed Creatine Fails to Augment the Benefits from Resistance Training in Patients with HIV Infection: A Randomized, Double-Blind, Placebo-Controlled Study
title_short Creatine Fails to Augment the Benefits from Resistance Training in Patients with HIV Infection: A Randomized, Double-Blind, Placebo-Controlled Study
title_sort creatine fails to augment the benefits from resistance training in patients with hiv infection: a randomized, double-blind, placebo-controlled study
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2646129/
https://www.ncbi.nlm.nih.gov/pubmed/19242554
http://dx.doi.org/10.1371/journal.pone.0004605
work_keys_str_mv AT sakkasgiorgosk creatinefailstoaugmentthebenefitsfromresistancetraininginpatientswithhivinfectionarandomizeddoubleblindplacebocontrolledstudy
AT mulligankathleen creatinefailstoaugmentthebenefitsfromresistancetraininginpatientswithhivinfectionarandomizeddoubleblindplacebocontrolledstudy
AT dasilvamakani creatinefailstoaugmentthebenefitsfromresistancetraininginpatientswithhivinfectionarandomizeddoubleblindplacebocontrolledstudy
AT doylejuliew creatinefailstoaugmentthebenefitsfromresistancetraininginpatientswithhivinfectionarandomizeddoubleblindplacebocontrolledstudy
AT khatamihootan creatinefailstoaugmentthebenefitsfromresistancetraininginpatientswithhivinfectionarandomizeddoubleblindplacebocontrolledstudy
AT schleichthomas creatinefailstoaugmentthebenefitsfromresistancetraininginpatientswithhivinfectionarandomizeddoubleblindplacebocontrolledstudy
AT kentbraunjanea creatinefailstoaugmentthebenefitsfromresistancetraininginpatientswithhivinfectionarandomizeddoubleblindplacebocontrolledstudy
AT schambelanmorris creatinefailstoaugmentthebenefitsfromresistancetraininginpatientswithhivinfectionarandomizeddoubleblindplacebocontrolledstudy